Genmab (NASDAQ:GMAB) is set to give its latest quarterly earnings report on Wednesday, 2024-02-14. Here’s what investors need to know before the announcement.
Analysts estimate that Genmab will report an earnings per share (EPS) of $4.02.
Genmab bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide …